In randomized trials in patients with atrial fibrillation (AF), treatment strategies that restore and maintain sinus rhythm (rhythm control) have not shown convincing advantages over those that simply ...

Old concerns about the safety of rhythm control drugs for atrial fibrillation (Afib or AF) resurfaced in a contemporary large Korean population-based study. Afib patients prescribed antiarrhythmic ...

Atrial fibrillation (AF) in older adults extends well beyond stroke prevention. Advancing age is the strongest demographic driver of AF prevalence and ...

Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

For patients with newly diagnosed atrial fibrillation, a quality improvement initiative improved access to specialist care ...

The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally ...

COMPASS presents a “scalable framework” for other centers that want to improve AF care, but additional efforts are needed.

A recent randomized trial in Czechia tested the premise that lifestyle modification and use of antiarrhythmic drugs was as effective as catheter ablation (CA) to treat atrial fibrillation (AF). The ...

The heart rhythm disorder called atrial fibrillation (AFib) can affect people of any age, but is most common in older adults. It may start with a rapid heartbeat, a fluttering feeling in a person’s ...

Atrial fibrillation (AFib) can lead to blood clots, stroke, heart failure, and other heart-related complications. New consumer patient research from the Dallas-based American Heart Association found ...

Irregular heartbeat conditions affect millions of people worldwide, causing hearts to beat too fast, too slow, or with an uneven rhythm. These cardiac rhythm disturbances, medically known as ...

What changed?: The COMPASS initiative boosted early rhythm control use in AF from 28.8% to 32.8% within six months of diagnosis. Specialist access up: Referrals to electrophysiologists rose from 22.6% ...